Description

Semaglutide is a long-acting synthetic analogue of glucagon-like peptide-1 (GLP-1). The molecule activates the GLP-1 receptor, a signalling pathway involved in glucose regulation, nutrient handling, gastric motility and appetite-related signalling.

Semaglutide is extensively studied in metabolic research. MMRR Semaglutide is supplied as a research material in 10 mg and 20 mg vial sizes; it is not represented as an approved pharmaceutical product. Every MMRR batch is independently third-party tested under the MMRR testing program.

Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.

Additional information

Size	10 mg, 20 mg

Reviews

There are no reviews yet.

Be the first to review “Semaglutide”

Independent third-party testing

Every MMRR product batch is independently tested by a third-party laboratory before release. Core analytical testing is designed to confirm identity, chromatographic purity and peptide content, with additional impurity, moisture, residual-solvent, elemental and microbiological testing used where applicable to the product and batch.

Testing is product- and batch-specific. MMRR does not treat a purity percentage as a substitute for identity, content or microbiological testing.

Read about MMRR testing ↗